Association of Chronic Kidney Disease with Cardiovascular Disease in Cancer Patients: A Cross-Sectional Study
Cardiorenal Medicine · 2023
DOI: 10.1159/000534182 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Cardiorenal Medicine, 2023. Verfasst von An-Bang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong First Medical University and Shandong Academy of Medical Sciences, Central Hospital Affiliated to Shandong First Medical University, Jinan, …. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Renal Insufficiency, Chronic, Diabetes Mellitus, Hypertension. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Due to the cardiotoxicity of cancer treatment and traditional risk factors for cardiovascular disease (CVD) such as obesity, diabetes, dyslipidemia, and hypertension, cancer patients are at higher risk of developing CVD. However, limited research exists on the correlation between chronic kidney disease (CKD) and CVD risk in cancer patients.
Methods
This cross-sectional study selected cancer patients aged ≥20 years from the National Health and Nutrition Examination Survey (NHANES) conducted from 2015 to 2020. Multivariable logistic regression was used to assess the association between CKD and CVD in cancer patients. Additionally, subgroup analyses were conducted to investigate the association among different groups of cancer patients.
Results
We included 1,700 adult cancer patients (52.53% were females). After multivariable adjustment for covariates including traditional CVD factors, CKD was significantly associated with CVD, with an odds ratio (95% confidence interval) and p value of 1.61 (1.18, 2.19) and 0.004. Subgroup analyses after multivariable adjustment showed a significant correlation between CKD and increased CVD risk in the following cancer patients: age ≥60 years, males, white ethnicity, and individuals with or without traditional CVD factors (obesity, diabetes, dyslipidemia, and hypertension).
Conclusions
CKD remains a significant factor in the higher risk of CVD among adult cancer patients in the United States, even after adjustment for traditional CVD risk factors. Therefore, to reduce the risk of CVD in cancer patients, it is important to treat CKD as a non-traditional risk factor for CVD and actively manage it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong First Medical University and Shandong Academy of Medical Sciences, Central Hospital Affiliated to Shandong First Medical University, Jinan, China, liuab163@163.com.
- Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, China, liuab163@163.com.
- Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Jinan Central Hospital, Shandong University, Jinan, China.
- Shandong First Medical University and Shandong Academy of Medical Sciences, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
- School of Clinical Medicine, Weifang Medical University, Weifang, China.
Zitieren
APA
Liu, A. B., Zhang, D., Meng, T. T., Zhang, Y., Tian, P., Chen, J. L., Zheng, Y., & Su, G. H. (2023). Association of Chronic Kidney Disease with Cardiovascular Disease in Cancer Patients: A Cross-Sectional Study. Cardiorenal Medicine. https://doi.org/10.1159/000534182
Vancouver
Liu AB, Zhang D, Meng TT, Zhang Y, Tian P, Chen JL, et al. Association of Chronic Kidney Disease with Cardiovascular Disease in Cancer Patients: A Cross-Sectional Study. Cardiorenal Medicine. 2023. doi:10.1159/000534182
BibTeX
@article{Liu2023,
author = {Liu, An-Bang and Zhang, Dan and Meng, Ting-Ting and Zhang, Yu and Tian, Peng and Chen, Jian-Lin and Zheng, Yan and Su, Guo-Hai},
title = {Association of Chronic Kidney Disease with Cardiovascular Disease in Cancer Patients: A Cross-Sectional Study},
journal = {Cardiorenal Medicine},
year = {2023},
doi = {10.1159/000534182}
}
EUVIMED